| scholarly article | Q13442814 |
| P50 | author | Judith J. Prochaska | Q59193684 |
| Stanton A Glantz | Q59194501 | ||
| P2093 | author name string | Janine K Cataldo | |
| P2860 | cites work | Forecasting the global burden of Alzheimer’s disease | Q22252403 |
| Free testosterone and risk for Alzheimer disease in older men | Q22306167 | ||
| Review of the quality of studies on the economic effects of smoke-free policies on the hospitality industry | Q24671492 | ||
| Pharmaceutical industry sponsorship and research outcome and quality: systematic review | Q24673248 | ||
| Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
| Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies | Q28143521 | ||
| Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies | Q28207349 | ||
| Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies | Q28306571 | ||
| Scope and impact of financial conflicts of interest in biomedical research: a systematic review | Q29616086 | ||
| Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study | Q30572719 | ||
| Does an interaction between smoking and drinking influence the risk of Alzheimer's disease? Results from three Canadian data sets | Q30597216 | ||
| The limits of competing interest disclosures | Q33213236 | ||
| Playing hide-and-seek with the tobacco industry | Q33213517 | ||
| Traditional reviews, meta-analyses and pooled analyses in epidemiology | Q33589615 | ||
| Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: a case-control study in northern England | Q33705543 | ||
| Aggregation of vascular risk factors and risk of incident Alzheimer disease | Q33989502 | ||
| Why review articles on the health effects of passive smoking reach different conclusions | Q34066636 | ||
| Implications of the tobacco industry documents for public health and policy | Q34157642 | ||
| The association between smoking and Alzheimer's disease: effects of study design and bias | Q34169575 | ||
| Tobacco industry manipulation of research | Q34412704 | ||
| Research into smoking or nicotine and human cognitive performance: does the source of funding make a difference? | Q34461721 | ||
| Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population | Q69522753 | ||
| The quality of drug studies published in symposium proceedings | Q71004282 | ||
| Smoking, Alzheimer's disease, and confounding with genes | Q72290782 | ||
| The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada | Q72829553 | ||
| Vascular risk factors, cognition and dementia incidence over 6 years in the Sydney Older Persons Study | Q73310174 | ||
| Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group | Q73570669 | ||
| Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction | Q73914894 | ||
| Association of Alzheimer's disease and smoking: the case for sibling controls | Q73998714 | ||
| Health habits and risk of cognitive impairment and dementia in old age: a prospective study on the effects of exercise, smoking and alcohol consumption | Q77321700 | ||
| Nicotine, Parkinson's and Alzheimer's disease | Q84076770 | ||
| Alcohol use and the risk of developing Alzheimer's disease. | Q34575249 | ||
| Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members | Q34737934 | ||
| Relation between nicotine intake and Alzheimer's disease | Q35179835 | ||
| Tobacco industry documents: treasure trove or quagmire? | Q35540374 | ||
| The shredding of BAT's defence: McCabe v British American Tobacco Australia | Q35564305 | ||
| Clinical implications of smoking and aging: breaking through the barriers | Q36918829 | ||
| Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature | Q36946413 | ||
| Cigarette smoking and dementia: potential selection bias in the elderly | Q37139022 | ||
| Smoking and dementia in male British doctors: prospective study | Q37326045 | ||
| Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States | Q38898082 | ||
| Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial | Q39406084 | ||
| The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population | Q39746495 | ||
| Association of amyloid precursor protein-binding protein, family B, member 1 with nicotine dependence in African and European American smokers. | Q40050093 | ||
| Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies | Q40504983 | ||
| Smoking and Alzheimer's disease: a review of the epidemiological evidence | Q40705975 | ||
| A case-control study of Alzheimer's disease in Australia | Q41198222 | ||
| A case-control study of Alzheimer's disease | Q41220542 | ||
| Are Alzheimer patients healthier? | Q41433477 | ||
| A case-control study of dementia of the Alzheimer type | Q41500631 | ||
| Does caffeine intake protect from Alzheimer's disease? | Q44051650 | ||
| Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group | Q44268497 | ||
| Comparison of Alzheimer's disease risk factors in white and African American families | Q44411561 | ||
| Development of dementing illnesses in an 80-year-old volunteer cohort | Q44754847 | ||
| A 2-year follow-up study of cigarette smoking and risk of dementia | Q44828259 | ||
| Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study | Q44884902 | ||
| Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study | Q44949032 | ||
| Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study | Q47887017 | ||
| Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains | Q48265799 | ||
| Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study | Q48338069 | ||
| Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. | Q50537933 | ||
| The influence of smoking on the risk of Alzheimer's disease. | Q50644766 | ||
| Risk factors for Alzheimer's disease: a case-control study. | Q50927996 | ||
| A cross-ethnic analysis of risk factors for AD in white Hispanics and white non-Hispanics. | Q52035280 | ||
| Alzheimer's disease: a study of epidemiological aspects. | Q52092341 | ||
| Case-control study of late onset "probable Alzheimer's disease". | Q52591389 | ||
| Alzheimer's disease and smoking: bias in cohort studies. | Q53027429 | ||
| Relation of smoking and alcohol consumption to incident Alzheimer's disease | Q53180386 | ||
| Clinical and epidemiological aspects of Alzheimer's disease with presenile onset: a case control study. | Q53185922 | ||
| Smoking as a risk factor for Alzheimer's disease. | Q53188960 | ||
| An epidemiological study of dementia in a rural community in Kerala, India. | Q53213103 | ||
| Smoking and oestrogen-replacement therapy as protective factors for Alzheimer's disease. | Q53216125 | ||
| A case-control study of smoking and Alzheimer's disease. | Q53217370 | ||
| Smoking and risk of Alzheimer's disease. MIRAGE Study Group. | Q53224118 | ||
| Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia. | Q53235124 | ||
| Prevalence of Alzheimer's type dementia in an elderly Arab population. | Q53241318 | ||
| Risk factors for Alzheimer's disease: a case-control study. | Q53306156 | ||
| Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. | Q53354093 | ||
| Influence of design characteristics on the outcome of retrospective cohort studies. | Q55489143 | ||
| Relation between smoking and risk of dementia and Alzheimer disease: The Rotterdam Study | Q57781910 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| smoking | Q662860 | ||
| risk factor | Q1475848 | ||
| cigarette smoking | Q67433631 | ||
| P304 | page(s) | 465-80 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
| P1476 | title | Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation | |
| P478 | volume | 19 |
| Q33632813 | "A delicate diplomatic situation": tobacco industry efforts to gain control of the Framingham Study |
| Q40507217 | A Human-Based Integrated Framework for Alzheimer's Disease Research |
| Q90701590 | A conflict of interest is strongly associated with tobacco industry-favourable results, indicating no harm of e-cigarettes |
| Q33869926 | A neurodegenerative vascular burden index and the impact on cognition |
| Q92416322 | Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology |
| Q35783506 | Age and Vascular Burden Determinants of Cortical Hemodynamics Underlying Verbal Fluency |
| Q37457369 | Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities |
| Q26825442 | Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers |
| Q47095504 | Alzheimer's disease and cigarette smoke components: effects of nicotine, PAHs, and Cd(II), Cr(III), Pb(II), Pb(IV) ions on amyloid-β peptide aggregation |
| Q89135993 | Alzheimer's disease and osteoporosis |
| Q35899503 | Alzheimer's disease: a clinical practice-oriented review |
| Q37288509 | Alzheimer's disease: analyzing the missing heritability |
| Q64060113 | Alzheimer's disease: risk factors and potentially protective measures |
| Q93015914 | Anti-Diabetic Countermeasures Against Tobacco Smoke-Dependent Cerebrovascular Toxicity: Use and Effect of Rosiglitazone |
| Q64075371 | Assessing the protective effect of rosiglitazone against electronic cigarette/tobacco smoke-induced blood-brain barrier impairment |
| Q36499962 | Association between environmental tobacco smoke exposure and dementia syndromes |
| Q48034096 | Associations of Spatial Disparities of Alzheimer's Disease Mortality Rates with Soil Selenium and Sulfur Concentrations and Four Common Risk Factors in the United States |
| Q64066752 | Autophagy alleviates the decrease in proliferation of amyloid β1‑42‑treated bone marrow mesenchymal stem cells via the AKT/mTOR signaling pathway |
| Q34496928 | Brain imaging of nicotinic receptors in Alzheimer's disease |
| Q35997881 | Brain metabolic dysfunction at the core of Alzheimer's disease |
| Q36959844 | CHRNA7 Polymorphisms and Dementia Risk: Interactions with Apolipoprotein ε4 and Cigarette Smoking |
| Q35646004 | Cancer 'survivor-care': I. the α7 nAChR as potential target for chemotherapy-related cognitive impairment |
| Q88394805 | Cardiovascular health and cognitive function among Mexican older adults: cross-sectional results from the WHO Study on Global Ageing and Adult Health |
| Q53386256 | Cardiovascular risk factors and glucose tolerance in midlife and risk of cognitive disorders in old age up to a 49-year follow-up of the Helsinki businessmen study. |
| Q34743183 | Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes |
| Q37715542 | Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition |
| Q35636099 | Chronic obstructive pulmonary disease, hospital visits, and comorbidities: National Survey of Residential Care Facilities, 2010. |
| Q35912013 | Cigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's Disease |
| Q52592587 | Cigarette smoke and nicotine effects on brain proinflammatory responses and behavioral and motor function in HIV-1 transgenic rats. |
| Q35231081 | Cigarette smoke induces DNA damage and alters base-excision repair and tau levels in the brain of neonatal mice |
| Q34273687 | Cigarette smoking accelerated brain aging and induced pre-Alzheimer-like neuropathology in rats |
| Q38925681 | Cigarette smoking behaviour and blood metabolomics |
| Q38761126 | Clinical and Environmental Correlates of Serum BDNF: A Descriptive Study with Plausible Implications for AD Research |
| Q89597781 | Comparative Analysis of Lipid Extracts and Imaging Mass Spectrometry for Evaluating Cerebral White Matter Biochemical Pathology in an Experimental Second-Hand Cigarette Smoke Exposure Model |
| Q89026250 | Conventional and electronic cigarettes dysregulate the expression of iron transporters and detoxifying enzymes at the brain vascular endothelium: In vivo evidence of a gender-specific cellular response to chronic cigarette smoke exposure |
| Q39820582 | Dementia and stroke: the present and future epidemic |
| Q36241900 | EVALUATION OF HOW CIGARETTE SMOKE IS A DIRECT RISK FACTOR FOR ALZHEIMER'S DISEASE. |
| Q58801779 | Effect of Cholesterol on Membrane Fluidity and Association of Aβ Oligomers and Subsequent Neuronal Damage: A Double-Edged Sword |
| Q57822469 | Effect of smoking cessation on the risk of dementia: a longitudinal study |
| Q92256567 | Effects of Blood Pressure on Cognitive Performance: A Systematic Review |
| Q28302380 | Electronic nicotine delivery system (electronic cigarette) awareness, use, reactions and beliefs: a systematic review |
| Q35920548 | Epidemiology of Alzheimer disease |
| Q34048078 | Evidence Regarding the Impact of Conflicts of Interest on Environmental and Occupational Health Research |
| Q34189447 | Gene-environment interaction research and transgenic mouse models of Alzheimer's disease |
| Q58920538 | Genetics of Alzheimer's disease |
| Q38820997 | Genome-wide meta-analysis identifies a novel susceptibility signal at CACNA2D3 for nicotine dependence |
| Q46709675 | Healthy behavior and memory self-reports in young, middle-aged, and older adults. |
| Q33462295 | History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress |
| Q92650020 | Hypothesis: Etiologic and Molecular Mechanistic Leads for Sporadic Neurodegenerative Diseases Based on Experience With Western Pacific ALS/PDC |
| Q38740560 | IP3 and calcium signaling involved in the reorganization of the actin cytoskeleton and cell rounding induced by cigarette smoke extract in human endothelial cells |
| Q35884677 | Impact of cigarette smoke extract and hyperglycemic conditions on blood-brain barrier endothelial cells |
| Q28072341 | Impacts of cigarette smoking on immune responsiveness: Up and down or upside down? |
| Q47789561 | Increased Serum Acylated Ghrelin Levels in Patients with Mild Cognitive Impairment |
| Q34035062 | Increased risk of dementia in patients exposed to nitrogen dioxide and carbon monoxide: a population-based retrospective cohort study |
| Q33689097 | Increased risk of dementia in patients with osteoporosis: a population-based retrospective cohort analysis |
| Q41996786 | Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains |
| Q37409026 | Interactive effects of chronic cigarette smoking and age on hippocampal volumes. |
| Q57022760 | Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease |
| Q92353504 | Mercury and Alzheimer's Disease: Hg(II) Ions Display Specific Binding to the Amyloid-β Peptide and Hinder Its Fibrillization |
| Q33712358 | Modifiable risk factors for Alzheimer disease and subjective memory impairment across age groups |
| Q33596708 | Molecular approaches in obesity studies |
| Q26999354 | Molecular mechanism of acrylamide neurotoxicity: lessons learned from organic chemistry |
| Q28396929 | Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease |
| Q89499035 | Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer's Disease, and Dementia: From FINGER to World-Wide FINGERS |
| Q24630774 | Neuropharmacological review of the nootropic herb Bacopa monnieri |
| Q34426718 | New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine |
| Q33825485 | Offsetting the impact of smoking and e-cigarette vaping on the cerebrovascular system and stroke injury: Is Metformin a viable countermeasure? |
| Q48546920 | Oxidative stress in the brain of cigarette smoke-induced noxiousness: neuroprotective role of Sesbania grandiflora |
| Q28389172 | Oxidative stress of office workers relevant to tobacco smoking and inner air quality |
| Q30235369 | Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis |
| Q35447921 | Periodontal disease associates with higher brain amyloid load in normal elderly |
| Q37199397 | Perturbations in blood phosphatidylcholine and sphingomyelin Fatty Acid composition in a sample population of cigarette smokers |
| Q37263442 | Population attributable fraction of modifiable risk factors for Alzheimer disease: A systematic review of systematic reviews |
| Q30418181 | RNA deep sequencing analysis reveals that nicotine restores impaired gene expression by viral proteins in the brains of HIV-1 transgenic rats |
| Q58915016 | Relation of secondhand smoking to mild cognitive impairment in older inpatients |
| Q40553951 | Relationship between cigarette smoking and hyperuricemia in middle-aged and elderly population: a cross-sectional study. |
| Q86529648 | Relationship between cigarette smoking and radiographic knee osteoarthritis in Chinese population: a cross-sectional study |
| Q37536747 | Risk factors for dementia with Lewy bodies: a case-control study |
| Q90736428 | Risk of Alzheimer's Disease in Cancer Patients: Analysis of Mortality Data from the US SEER Population-Based Registries |
| Q33902721 | Smoking and increased Alzheimer's disease risk: a review of potential mechanisms |
| Q40164691 | Smoking cessation and Alzheimer's disease: facts, fallacies and promise |
| Q43516778 | Smoking exacerbates amyloid pathology in a mouse model of Alzheimer's disease. |
| Q33717852 | Smoking history and Alzheimer's disease risk in a community-based clinic population |
| Q35170855 | Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers |
| Q35874663 | Smoking, death, and Alzheimer disease: a case of competing risks |
| Q87354667 | Targeted studies on the interaction of nicotine and morin molecules with amyloid β-protein |
| Q47188911 | Targeting Neuroinflammation to Treat Alzheimer's Disease. |
| Q55266969 | The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at 'Type 3 Diabetes', Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments. |
| Q55381143 | The Role of Genetics in Advancing Precision Medicine for Alzheimer's Disease-A Narrative Review. |
| Q93265117 | The cerebrovascular and neurological impact of chronic smoking on post-traumatic brain injury outcome and recovery: an in vivo study |
| Q37704441 | The effect of funding sources on donepezil randomised controlled trial outcome: a meta-analysis |
| Q64272063 | The effects of bioactive components from the rhizome of (Danshen) on the characteristics of Alzheimer's disease |
| Q33887372 | The nicotinic acetylcholine receptor: smoking and Alzheimer's disease revisited |
| Q36825862 | The projected effect of risk factor reduction on Alzheimer's disease prevalence |
| Q40196229 | Tobacco Smoke Exposure Impairs Brain Insulin/IGF Signaling: Potential Co-Factor Role in Neurodegeneration |
| Q41566472 | Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration. |
| Q92267911 | Tobacco Smoking and Dementia in a Kentucky Cohort: A Competing Risk Analysis |
| Q46234007 | Tobacco papers and tobacco industry ties in regulatory toxicology and pharmacology |
| Q55003935 | Towards an Integrative Understanding of tRNA Aminoacylation-Diet-Host-Gut Microbiome Interactions in Neurodegeneration. |
| Q42376534 | Unhealthy smokers: scopes for prophylactic intervention and clinical treatment. |
Search more.